Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains

Int J Dev Neurosci. 2000 Dec;18(8):807-13.

Abstract

In the present study, we investigated the levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in post-mortem brain tissue of Alzheimer's disease (AD) patients, and we observed a significant increase of BDNF concentration in hippocampus and parietal cortex of AD patients, as well as a negative correlation between NT-3 levels and age in hippocampus and putamen of control subjects, and for BDNF in frontal cortex. A defining feature of AD is the post-mortem identification of neuritic plaques and neurofibrillary tangles in the brain, however, a more significant neuropathological finding is the degeneration of cholinergic neurones of the basal forebrain, critically involved in memory and cognition. Neurotrophic factors are partly responsible for the maintenance of neuronal function and structural integrity in the adult brain. Our results provide, therefore, evidence that, under conditions of progressive neurodegeneration the brain stimulates the over expression of certain neurotrophic factors as a possible mechanisms of compensation, and that during senescence the expression of these molecules is regulated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Brain Chemistry*
  • Brain-Derived Neurotrophic Factor / analysis*
  • Cholinergic Fibers / chemistry
  • Cholinergic Fibers / pathology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Frontal Lobe / chemistry
  • Frontal Lobe / pathology
  • Humans
  • Male
  • Middle Aged
  • Neurotrophin 3 / analysis*
  • Postmortem Changes
  • Putamen / chemistry
  • Putamen / pathology
  • Sex Factors

Substances

  • Brain-Derived Neurotrophic Factor
  • Neurotrophin 3